Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors That Are MTAP Deficient

Explore clinical trials studying Advanced Solid Tumors That Are MTAP Deficient. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Advanced Solid Tumors That Are MTAP Deficient trial results

Recruiting

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

NCT06130553

Conditions
Advanced Solid Tumors That Are MTAP Deficient
Locations
  • Research Site San Francisco, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Baltimore, Maryland, United States
View all 21 locations
View Trial Details